In continuation to our communication in accordance SERI Circular No. SEBI/HO/MIRSD/DOP/CIR/P/2020/28
dated February 25, 2020 in connection with the Pledge and Re-Pledge of securities
with Clearing Member / Clearing Corporation.
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,Mumbai,Maharashtra-400026
Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 640.85. Its current market capitalisation stands at Rs 18082.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 67126.31 Cr and Total Income of Rs.73194.19 Cr. The company's management includes Dipankar Bhattacharjee, Harish Kuber, Saira Ramasastry, D R Mehta, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha. It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP
© NIRMAL BANG. All rights reserved
Designed , Developed & Content Powered by ●●●
Accord Fintech Pvt. Ltd.
Please fill in the details below
(Note - You will receive a call from our sales executive)
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document,
Do's & Don't's) in Vernacular Language :